Oral lipid prodrug V2043 (1-O-octadecyl-2-O-benzyl-sn-glyceryl-P-remdesivir nucleoside) protects mice from lethal dengue infection.

Clark AE, Erlich JR, Beadle JR, McMillan RE, Xie J, Garretson AF, Atkins S, Sharma A, Rajan SM, Croker BA, Schooley RT, Hostetler KY, Carlin AF

Open source

DOI
10.1128/aac.00401-26
Published
2026 Sep 2
Container
Antimicrobial agents and chemotherapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/aac.00401-26,
  title = {Oral lipid prodrug V2043 (1-O-octadecyl-2-O-benzyl-sn-glyceryl-P-remdesivir nucleoside) protects mice from lethal dengue infection.},
  author = {Clark AE and Erlich JR and Beadle JR and McMillan RE and Xie J and Garretson AF and Atkins S and Sharma A and Rajan SM and Croker BA and Schooley RT and Hostetler KY and Carlin AF},
  year = {2026},
  journal = {Antimicrobial agents and chemotherapy},
  doi = {10.1128/aac.00401-26},
  url = {https://doi.org/10.1128/aac.00401-26}
}

RIS

TY  - JOUR
TI  - Oral lipid prodrug V2043 (1-O-octadecyl-2-O-benzyl-sn-glyceryl-P-remdesivir nucleoside) protects mice from lethal dengue infection.
AU  - Clark AE
AU  - Erlich JR
AU  - Beadle JR
AU  - McMillan RE
AU  - Xie J
AU  - Garretson AF
AU  - Atkins S
AU  - Sharma A
AU  - Rajan SM
AU  - Croker BA
AU  - Schooley RT
AU  - Hostetler KY
AU  - Carlin AF
PY  - 2026
JO  - Antimicrobial agents and chemotherapy
DO  - 10.1128/aac.00401-26
UR  - https://doi.org/10.1128/aac.00401-26
ER  - 

APA

AE, C., JR, E., JR, B., RE, M., J, X., AF, G., S, A., A, S., SM, R., BA, C., RT, S., KY, H., & AF, C. (2026). Oral lipid prodrug V2043 (1-O-octadecyl-2-O-benzyl-sn-glyceryl-P-remdesivir nucleoside) protects mice from lethal dengue infection.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.00401-26

Source records